Drug markets and patterns of misuse shifted significantly in 2023\u20132025, with rising stimulant use in Europe and the Americas, persistent opioid and tramadol misuse in parts of the Middle East, and a continued burden of alcohol and cannabis in India and the USA. Understanding regional differences \u2014 and the trauma and family harm that lie behind them \u2014 is essential for designing effective, trauma\u2011informed rehabilitation programmes. This article summarises the most recent international evidence and outlines a patient\u2011centred model of care offered at Hope Rehab & Wellness, Delhi.<\/p>\n
The UK continues to report high and rising rates of stimulant use \u2014 notably cocaine and ketamine \u2014 alongside widespread cannabis consumption. The Office for National Statistics and NHS data show increased treatment demand, rising hospital admissions related to stimulants, and growing concerns about the mental\u2011health consequences of chronic ketamine exposure. Families commonly report secrecy, financial strain and relational breakdowns when a member develops problematic stimulant or cannabis use.<\/p>\n
In the United States, polysubstance patterns include alcohol, prescription opioid misuse (including tramadol in some regions), and a continuing rise in synthetic drugs and cocaine in certain urban markets. National surveys and NIDA reports emphasise that medication\u2011assisted treatment and integrated mental\u2011health services are critical components of effective care. Community and family impacts are profound: untreated addiction contributes to family breakdown, child neglect and long\u2011term socioeconomic consequences.<\/p>\n
India faces a complex and growing substance\u2011use challenge: alcohol remains the most commonly used psychoactive substance, while opioids, cannabis, and increasingly synthetic drugs contribute to regional epidemics. National surveys and task\u2011force reports note substantial treatment gaps \u2014 with many people never accessing evidence\u2011based care. Policy discussions in 2024\u20132025 highlight the need to shift emphasis from criminalization to care and rehabilitation.<\/p>\n
The Eastern Mediterranean region faces a distinct profile: Captagon (fenethylline) seizures and amphetamine\u2011type stimulant availability have surged, tramadol misuse is widespread in several countries, and traditional stimulants such as khat persist in parts of the region. These patterns occur in the context of political instability, displacement and trauma, intensifying family and community harms.<\/p>\n
Robust evidence links adverse childhood experiences, conflict exposure and chronic stress with elevated risk for substance use disorders. Trauma alters neurobiological reward circuits and stress responsivity, increasing the likelihood that individuals will use substances to self\u2011medicate. Clinical programmes that ignore trauma are more likely to see relapse; conversely, trauma\u2011informed therapies reduce symptom burden and improve retention in care.<\/p>\n
Addiction causes emotional insecurity, intergenerational trauma and financial distress within households. Children of parents with substance use disorders are at higher risk of neglect and mental\u2011health problems. Family\u2011centred rehabilitation restores relational safety through psychoeducation, structured family therapy and relapse\u2011prevention planning.<\/p>\n